Streetinsider.com After-Hours Movers 07/25: (ETRM) (LOGM) (SBUX) Higher; (EXPE) (SWI) (ZNGA) Lower (more...)

July 25, 2013 6:08 PM EDT Send to a Friend
Expedia (NASDAQ: EXPE) 23.6% LOWER; reported Q2 EPS of $0.64, $0.15 worse than the analyst estimate of $0.79. Revenue for the quarter came in at $1.21 billion versus the consensus estimate of $1.26 billion.

Solarwinds (NYSE: SWI) 21% LOWER; reported Q2 EPS of $0.40, $0.04 better than the analyst estimate of $0.36. Revenue for the quarter came in at $77.5 million versus the consensus estimate of $78.94 million. Solarwinds sees Q3 2013 EPS of $0.35-$0.36, versus the consensus of $0.39. Solarwinds sees Q3 2013 revenue of $84.7-87.2 million, versus the consensus of $90.45 million. Solarwinds sees FY2013 EPS of $1.51-$1.54, versus the consensus of $1.55. Solarwinds sees FY2013 revenue of $322.7-327.7 million, versus the consensus of $336.64 million.

EnteroMedics Inc. (NASDAQ: ETRM) 19.6% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's Premarket Approval (PMA) application for approval of the Maestro Rechargeable System's VBLOC vagal blocking therapy as a treatment for obesity.

Zynga (Nasdaq: ZNGA) 13.4% LOWER; reported Q2 EPS of ($0.01), $0.03 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $230.7 million versus the consensus estimate of $185.42 million. The company noted: Zynga believes its biggest opportunity is to focus on free to play social games. While the Company continues to evaluate its real money gaming products in the United Kingdom test, Zynga is making the focused choice not to pursue a license for real money gaming in the United States. Zynga will continue to evaluate all of its priorities against the growing market opportunity in free, social gaming, including social casino offerings.

Tempur-Pedic International, Inc. (NYSE: TPX) 10.6% LOWER; reported Q2 EPS of $0.36, $0.04 worse than the analyst estimate of $0.40. Revenue for the quarter came in at $660.6 million versus the consensus estimate of $663.6 million. Tempur-Pedic International, Inc. sees FY2013 EPS of $2.25-$2.40, versus the consensus of $2.75. Tempur-Pedic International, Inc. sees FY2013 revenue of $2.425-2.450 billion, versus the consensus of $2.50 billion.

Logmein, Inc. (NASDAQ: LOGM) 10.6% HIGHER; reported Q2 EPS of $0.13, $0.01 better than the analyst estimate of $0.12. Revenue for the quarter came in at $40.7 million versus the consensus estimate of $39.31 million. Logmein, Inc. sees FY2013 EPS of $0.49-$0.52, versus the consensus of $0.49. Logmein, Inc. sees FY2013 revenue of $162.7-164.2 million, versus the consensus of $159.2 million.

Vertex Pharmaceuticals (Nasdaq: VRTX) 9.7% LOWER; received notice from the U.S. Food and Drug Administration (FDA) that a partial clinical hold has been placed on Vertexs ongoing Phase 2 U.S. study of the nucleotide analogue hepatitis C virus (HCV) polymerase inhibitor VX-135. The partial clinical hold prevents evaluation of a 200 mg dose of VX-135 in the U.S. study following observation of reversible elevated liver enzymes in patients receiving 400 mg of VX-135 in combination with ribavirin in a Phase 2 study in Europe. Evaluation of a 100 mg dose of VX-135 in combination with ribavirin as part of the 12-week Phase 2 study in the U.S. is continuing as planned.

Global Payments, Inc. (NYSE: GPN) 9.4% LOWER; reported Q4 EPS of $0.98, $0.04 worse than the analyst estimate of $1.02. Revenue for the quarter came in at $618.4 million versus the consensus estimate of $635.63 million. Global Payments, Inc. sees FY2014 EPS of $3.93-$4.00, versus the consensus of $3.69. Global Payments, Inc. sees FY2014 revenue of $2.51-2.56 billion, versus the consensus of $2.4 billion. Board of Directors approved a new $250 million share repurchase authorization of Global Payments' stock.

Qlik Technologies, Inc. (NASDAQ: QLIK) 8.3% LOWER; reported Q2 EPS of ($0.02), $0.01 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $108 million versus the consensus estimate of $106.54 million. Qlik Technologies, Inc. sees Q3 2013 EPS of $0.02-$0.04, versus the consensus of $0.07. Qlik Technologies, Inc. sees Q3 2013 revenue of $105-109 million, versus the consensus of $108.64 million. Qlik Technologies, Inc. sees FY2013 EPS of $0.37-$0.41, versus the consensus of $0.42. Qlik Technologies, Inc. sees FY2013 revenue of $473.0-481.0 million, versus the consensus of $477.82 million.

Telecommunication Systems, Inc. (NASDAQ: TSYS) 8.2% LOWER; reported Q3 EPS of ($0.01), $0.03 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $92.8 million versus the consensus estimate of $101.02 million.

Starbucks Corp (NASDAQ: SBUX) 6.4% HIGHER; reported Q3 EPS of $0.55, $0.02 better than the analyst estimate of $0.53. Revenue for the quarter came in at $3.74 billion versus the consensus estimate of $3.72 billion.

HomeAway (NASDAQ: AWAY) 6.4% LOWER; reported Q2 EPS of $0.16, $0.02 better than the analyst estimate of $0.14. Revenue for the quarter came in at $86.6 million versus the consensus estimate of $85.72 million.

Cirrus Logic, Inc. (NASDAQ: CRUS) 6.2% LOWER; reported Q1 EPS of $0.56, $0.07 better than the analyst estimate of $0.49. Revenue for the quarter came in at $155 million versus the consensus estimate of $160.12 million. Cirrus Logic, Inc. sees Q2 2014 revenue of $170-190 million, versus the consensus of $189.99 million

Maxim Integrated Products (NASDAQ: MXIM) 6% LOWER; reported Q4 EPS of $0.44, $0.03 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $608 million versus the consensus estimate of $626.24 million. Maxim Integrated Products sees Q1 2013 revenue of $570-600 million, versus the consensus of $648 million.

dELiA*s, Inc. (NASDAQ: DLIA) 5.8% LOWER; commenced an underwritten public offering of its common stock pursuant to its existing shelf registration statement.

Gilead Sciences, Inc. (NASDAQ: GILD) 5.6% HIGHER; reported Q2 EPS of $0.50, in-line with the analyst estimate of $0.50. Revenue for the quarter came in at $2.77 billion versus the consensus estimate of $2.66 billion. Also, Partial hold for Vertex Pharmaceuticals (VRTX) hep C trial.

Deckers Outdoor Corp (NASDAQ: DECK) 4.3% LOWER; reported Q2 EPS of ($0.85), $0.19 better than the analyst estimate of ($1.04). Revenue for the quarter came in at $170.1 million versus the consensus estimate of $179.4 million. Based on results for the first six months of 2013 combined with higher projections for the Company’s direct to consumer channel driven by stronger eCommerce sales trends and the planned opening of approximately 36 new stores, up from its previous plan of approximately 30, the Company is raising its full year outlook. The Company now expects full year revenues to increase approximately 8% over 2012 levels, up from its previous projection of approximately 7%. The Company now expects full year diluted earnings per share to increase approximately 8% over 2012 levels, up from its previous projection of approximately 5%. The Company currently expects third quarter 2013 revenue to increase approximately 2.5% and diluted earnings per share to decrease approximately 41% from 2012 levels. The Company currently expects fourth quarter 2013 revenue to increase approximately 14.5% and diluted earnings per share to increase approximately 38% over 2012 levels

priceline.com (NASDAQ: PCLN) 4.3% LOWER; lower on weak results from Expedia

Orbitz Worldwide, Inc. (NYSE: OWW) 4.3% LOWER; lower on weak results from Expedia

Mitek Systems (Nasdaq: MITK) 3.6% HIGHER; reported Q3 EPS of ($0.05), $0.03 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $3.9 million versus the consensus estimate of $3.09 million.

Cliffs Natural Resources (NYSE: CLF) 3.5% HIGHER; reported Q2 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $1.49 billion versus the consensus estimate of $1.43 billion.

Amazon.com, Inc. (NASDAQ: AMZN) 2% LOWER; reported Q2 EPS of ($0.08), $0.13 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $15.7 billion versus the consensus estimate of $15.73 billion. Amazon.com, Inc. sees Q3 2013 revenue of $14.45-17.15 billion, versus the consensus of $16.98 billion. Operating loss is expected to be between $440 million and $65 million, compared to $28 million in third quarter 2012.

Flextronics International Ltd (NASDAQ: FLEX) 2% HIGHER; reported Q1 EPS of $0.18, $0.04 better than the analyst estimate of $0.14. Revenue for the quarter came in at $5.79 billion versus the consensus estimate of $5.45 billion. Flextronics International Ltd sees Q2 2013 EPS of $0.21, versus the consensus of $0.2. Flextronics International Ltd sees Q2 2013 revenue of $6.1-6.4 billion, versus the consensus of $6.11 billion.

Encore Wire Corp (NASDAQ: WIRE) 1.1% HIGHER; reported Q2 EPS of $0.75, $0.45 better than the analyst estimate of $0.30. Revenue for the quarter came in at $289.5 million versus the consensus estimate of $252 million.

CBS Corporation (NYSE: CBS) 0.9% HIGHER; said its board expanded its share repurchase program to a total availability of $6 billion, an increase of $5.1 billion. Since the share repurchase program was initiated in January 2011, through the end of the second quarter of 2013, CBS has returned $3.75 billion of value to its shareholders.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

After-Hours Movers, Stock Buyback, Earnings

Add Your Comment